...
首页> 外文期刊>Pharmacogenomics >Pharmacogenomics of the heptahelical receptor regulators G-protein-coupled receptor kinases and arrestins: the known and the unknown.
【24h】

Pharmacogenomics of the heptahelical receptor regulators G-protein-coupled receptor kinases and arrestins: the known and the unknown.

机译:七螺旋受体调节剂的G-蛋白偶联受体激酶和抑制蛋白的药物基因组学:已知和未知。

获取原文
获取原文并翻译 | 示例
           

摘要

Heptahelical G-protein-coupled receptors are the most diverse and therapeutically important family of receptors, playing major roles in the physiology of various organs and tissues. They couple their ligand binding to G-protein activation, which then transmits intracellular signals. G-protein signaling is terminated by phosphorylation of the receptor by the family of G-protein-coupled receptor kinases (GRKs), followed by arrestin (Arr) binding, which uncouples the phosphorylated receptor from the G-protein and subsequently targets the receptor for internalization. Moreover, Arrs can transmit signals in their own right during receptor internalization. Genetic polymorphisms in receptors, as well as in GRK and Arr family members per se, which affect regulation of receptor signaling and function, have just started being identified and characterized. The present review will discuss what is known so far in this evolving field of GRK/Arr pharmacogenomics, as well as highlight important areas likely to produce invaluable information in the future.
机译:庚型G蛋白偶联受体是最多样化和治疗上重要的受体家族,在各种器官和组织的生理学中起主要作用。他们将配体结合到G蛋白活化,然后传递细胞内信号。 G蛋白偶联受体激酶(GRK)家族通过受体的磷酸化作用终止G蛋白信号传导,随后通过抑制蛋白(Arr)结合使磷酸化受体与G蛋白解偶联,并随后将受体靶向于内部化。此外,在受体内化过程中,Arrs可以自行传输信号。受体,以及影响受体信号和功能调节的GRK和Arr家族成员本身的遗传多态性刚刚开始被鉴定和表征。本综述将讨论在GRK / Arr药物基因组学这个不断发展的领域中迄今为止已知的知识,并重点介绍将来可能会产生宝贵信息的重要领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号